Integrated Wealth Concepts LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 27.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 934 shares of the financial services provider’s stock after selling 359 shares during the period. Integrated Wealth Concepts LLC’s holdings in CME Group were worth $222,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Qube Research & Technologies Ltd raised its stake in shares of CME Group by 186.5% during the fourth quarter. Qube Research & Technologies Ltd now owns 101,641 shares of the financial services provider’s stock valued at $23,221,000 after purchasing an additional 66,161 shares in the last quarter. Dowling & Yahnke LLC lifted its stake in shares of CME Group by 1.0% in the 4th quarter. Dowling & Yahnke LLC now owns 8,426 shares of the financial services provider’s stock worth $1,925,000 after acquiring an additional 80 shares during the period. Aviva PLC boosted its holdings in shares of CME Group by 3.6% in the fourth quarter. Aviva PLC now owns 113,737 shares of the financial services provider’s stock valued at $25,984,000 after acquiring an additional 4,000 shares in the last quarter. Krane Funds Advisors LLC acquired a new position in shares of CME Group during the fourth quarter valued at approximately $365,000. Finally, Teacher Retirement System of Texas raised its holdings in CME Group by 21.7% during the fourth quarter. Teacher Retirement System of Texas now owns 69,465 shares of the financial services provider’s stock worth $15,870,000 after purchasing an additional 12,408 shares in the last quarter. Institutional investors own 85.56% of the company’s stock.
CME Group Price Performance
CME opened at $200.34 on Thursday. The stock has a fifty day moving average price of $201.29 and a 200 day moving average price of $213.98. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1 year low of $185.79 and a 1 year high of $256.94. The stock has a market cap of $72.01 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 3.13 and a beta of 0.40.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 27th. Investors of record on Friday, September 9th will be paid a $1.00 dividend. This represents a $4.00 annualized dividend and a dividend yield of 2.00%. The ex-dividend date is Thursday, September 8th. CME Group’s payout ratio is presently 49.63%.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Argus upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Monday, May 16th. Oppenheimer raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $223.00 price target for the company in a report on Wednesday, May 25th. Credit Suisse Group dropped their target price on shares of CME Group from $216.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday. Deutsche Bank Aktiengesellschaft raised their target price on shares of CME Group from $208.00 to $212.00 and gave the stock a “hold” rating in a report on Friday, August 12th. Finally, Raymond James cut CME Group from an “outperform” rating to a “market perform” rating in a report on Monday, August 15th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $230.80.
Insider Buying and Selling
In other CME Group news, Director Daniel R. Glickman sold 500 shares of the firm’s stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total transaction of $98,195.00. Following the transaction, the director now directly owns 14,597 shares in the company, valued at $2,866,704.83. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, insider Hilda Harris Piell sold 4,901 shares of the firm’s stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $203.88, for a total value of $999,215.88. Following the sale, the insider now directly owns 33,140 shares of the company’s stock, valued at $6,756,583.20. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total value of $98,195.00. Following the transaction, the director now directly owns 14,597 shares of the company’s stock, valued at approximately $2,866,704.83. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
- Get a free copy of the StockNews.com research report on CME Group (CME)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.